Chief Medical Officer and Vice President Global Medical, Clinical & Health Affairs, Medtronic Diabetes

Emeritus Professor of Pediatrics and Communications at USC, The Center for Diabetes, Endocrinology & Metabolism

DrFrancine Ratner Kaufman, M.D. has had a 30 year distinguished career in diabetes care, research and advocacy. In 2009, she stepped down as director of the Comprehensive Childhood Diabetes Center, and head of the Center for Endocrinology, Diabetes and Metabolism at Childrens Hospital Los Angeles to become Chief Medical Officer and VP of Global Clinical, Medical and Health affairs at Medtronic Diabetes (Northridge, CA).

Dr. Kaufman is also a Distinguished Professor Emerita of Pediatrics and Communications at the Keck School of Medicine and the Annenberg School of Communications of the University of Southern California, and an attending physician at Childrens Hospital Los Angeles.

Dr. Kaufman has published more than 200 peer-reviewed and invited publications. She is the author of more than 30 books or book chapters. In 2008, she edited the 5th edition of the ADA’s the Medical Management of Type 1 Diabetes. In 2005 her book, Diabesity, was published by Bantam. Diabesity explores the ravages of the obesity and diabetes epidemics as they spread across the globe. Dr. Kaufman was chair of the National Institutes of Health funded Studies to Treat (the TODAY Trial) and Prevent (the HEALTHY Trial) Type 2 Diabetes in Youth (STOPP-T2). She was a principal investigator of TrialNet, a multinational consortium evaluating ways to prevent type 1 diabetes, funded by the National Institutes of Health (NIH). She has received many awards and honors, including the LA City Council for promoting youth physical fitness (2004), from the State of California for her role in banning sodas from Los Angeles Unified School District (2003), and from the American Diabetes Association (ADA), Juvenile Diabetes Research Foundation (JDRF), European Association for the Study of Diabetes (EASD), Partners in Care, Starbright Foundation, amongst others.

In 2009, Dr. Kaufman was elected to membership in the Advisory Council of the Diabetes Branch of the NIH. In 2007, she filmed a documentary for Discovery Health on the global diabetes epidemic which was aired around the world on World Diabetes Day, November 14, 2007. Also in 2007, Dr. Kaufman was Co-Chair of the Diabetes Work Group for the Department of Health Services of the State of California to recommend diabetes treatment and prevention strategies for the Medicaid population. In 2005, she was elected Membership in the Institute of Medicine. Dr. Kaufman was national president of the American Diabetes Association in 2002-03. She was elected to AOA Medical Honorary Society. She was also president of Shaping America’s Health, chair of the National Diabetes Education Program, and served as chair of the Youth Consultative Section of the International Diabetes Federation.

 


An important new FDA Approval for Pediatric Patients with Type 1 Diabetes

I am delighted to share that our MiniMed™ 670G hybrid closed loop system has been FDA approved for children with Type 1 diabetes aged seven years and older! This is a very important milestone for younger patients and their caregivers, as access to this groundbreaking therapy will help alleviate some of the burden associated with […]Read More »

Three Days in Puerto Rico

After driving through the streets with rubble, no traffic lights, downed trees and power lines, and being aware that electricity remains an elusive necessity throughout the island, I boarded my plane to leave Puerto Rico. Although I was there for only 3 days, I had an amazing opportunity to view our Juncos plant (which is […]Read More »

Frank Buckley Interviews: MiniMed 670G System

KTLA 5 morning news, Frank Buckley, knows firsthand what it means to care for someone with type 1 diabetes. As Frank’s son’s endocrinologist, we discuss the challenges of diabetes, the innovation leading to the MiniMed 670G system approval, and what’s next. MiniMed® 670G System The Medtronic MiniMed 670G system requires a prescription and is intended […]Read More »

Advances Toward an Artificial Pancreas

For people with type 1 diabetes, the day-to-day management can be a full-time job. We have been working toward the development of an artificial pancreas, focusing on shifting the burden of managing diabetes from the person to the system. Listen to my podcast with The Bio Report to learn more about the progress we’ve made […]Read More »